QR-kod

Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report

Abstract Background Severe epistaxis is often difficult to control in patients with hereditary hemorrhagic telangiectasia (HHT). Propranolol has been shown to have antiangiogenic properties in vitro and in vivo and is commonly used to treat hemangiomas. We present our experience with topical nasal p...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphov: Meir Mei-Zahav, Hannah Blau, Elchanan Bruckheimer, Eyal Zur, Neta Goldschmidt
Materialtyp: Artigo
Språk:Inglês
Utgiven: SAGE Publishing 2017-10-01
Serie:Journal of Otolaryngology - Head and Neck Surgery
Ämnen:
Länkar:http://link.springer.com/article/10.1186/s40463-017-0235-x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!